Category: Altoida

  • Eisai-backed trial will assess Altoida’s digital test for early Alzheimer’s

    A software platform developed by Altoida that uses augmented reality and artificial intelligence to diagnose neurological diseases in their earliest stages is being tested in a five-year trial involving thousands of patients. The trial – which will be supported by pharma company Eisai and Ionian University in the US – will see if the test […]